Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant thrombomodulin domain 1 for use in treating eye diseases associated with pathological ocular angiogenesis

Recombinant thrombomodulin domain 1 for use in treating eye diseases associated with pathological ocular angiogenesis

US Patent 11338019 · Granted May 24, 2022

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for removing heavy metal from water2025
Method for producing photocatalytic mortar2025
Ungulate-derived polyclonal immunoglobulin specific for coronavirus protein and 2024
Systems and methods for the production of human polyclonal antibodies2021
Composition for use in promoting wound healing2019
TMD1 protein for treating bone loss diseases2017
Methods for treatment of CD14-mediated disorders and responses2017
Combined vaccines for prevention of porcine virus infections2017
Thrombomodulin variants and use thereof2015
Pharmacological treatment of aortic aneurysm development2015
Attenuated live vaccine for prevention of porcine reproductive and respiratory s2014
Detection and analysis apparatus for membrane filtration process2012